glp 1 latest news GLP-1 weight loss drugs leave users low on key nutrients, study finds GLP-1 Pipeline Update: August 2025

Know their benefits, effectiveness, and why working with a licensed provider is vital.

Several studies suggest that 15%-40% of IBD patients are obese

PlexusDx explains the mechanism behind these symptoms and practical strategies to reduce discomfort during your weight loss treatment

however, this contradicts established trial data favoring SGLT2 inhibitors for heart failure and should be interpreted cautiously due to possible residual confounding

The papers reviewed revealed that GLP-1 analogues may have beneficial effects on additional weight loss and T2D remission postoperatively

SaveHealth reports that Zepbound and Wegovy, both FDA-approved weight loss injectables, differ in mechanisms and efficacy